Antithrombotic therapy in cancer.
Lemoine
Nicholas R
NR
D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000502:physiology; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D016019:Survival Analysis
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight